{"nct_id":"NCT03783923","title":"A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)","status":"TERMINATED","status_verified_date":"2022-05","start_date":"2019-10-31","start_date_type":"ACTUAL","primary_completion_date":"2021-01-01","primary_completion_date_type":"ACTUAL","completion_date":"2021-01-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PTCT"]}